Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

BUY
$3.38 - $4.22 $32,265 - $40,284
9,546 Added 35.1%
36,744 $134,000
Q2 2022

Aug 09, 2022

SELL
$4.41 - $5.69 $29,564 - $38,145
-6,704 Reduced 19.77%
27,198 $144,000
Q4 2021

Feb 01, 2022

BUY
$5.97 - $7.93 $122,964 - $163,334
20,597 Added 154.81%
33,902 $231,000
Q2 2021

Jul 30, 2021

SELL
$5.35 - $6.35 $32,319 - $38,360
-6,041 Reduced 31.23%
13,305 $79,000
Q2 2020

Jul 28, 2020

BUY
$4.5 - $7.02 $43,096 - $67,230
9,577 Added 98.03%
19,346 $128,000
Q1 2019

Apr 29, 2019

BUY
$5.16 - $6.85 $6,088 - $8,083
1,180 Added 13.74%
9,769 $61,000
Q2 2018

Aug 06, 2018

BUY
$5.19 - $7.25 $26,920 - $37,605
5,187 Added 152.47%
8,589 $57,000
Q3 2017

Nov 08, 2017

BUY
$2.22 - $2.73 $7,552 - $9,287
3,402
3,402 $9,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $351M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.